Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group.
Brown RA, Wolff SN, Fay JW, Pineiro L, Collins RH Jr, Lynch JP, Stevens D, Greer J, Herzig RH, Herzig GP. Brown RA, et al. Among authors: lynch jp. Blood. 1995 Mar 1;85(5):1391-5. Blood. 1995. PMID: 7858269 Free article. Clinical Trial.
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
Brown RA, Wolff SN, Fay JW, Pineiro L, Collins RH Jr, Lynch JP, Stevens D, Greer J, Herzig RH, Herzig GP. Brown RA, et al. Among authors: lynch jp. Leuk Lymphoma. 1996 Jul;22(3-4):271-7. doi: 10.3109/10428199609051758. Leuk Lymphoma. 1996. PMID: 8819076 Clinical Trial.
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer.
Bernstein SH, Eaves CJ, Herzig R, Fay J, Lynch J, Phillips GL, Christiansen N, Reece D, Ericson S, Stephan M, Kovalsky M, Hawkins K, Rasmussen H, Devos A, Herzig GP. Bernstein SH, et al. Br J Haematol. 1997 Dec;99(4):888-95. doi: 10.1046/j.1365-2141.1997.4913294.x. Br J Haematol. 1997. PMID: 9432038 Free article. Clinical Trial.
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN, Fay J, Stevens D, Herzig RH, Pohlman B, Bolwell B, Lynch J, Ericson S, Freytes CO, LeMaistre F, Collins R, Pineiro L, Greer J, Stein R, Goodman SA, Dummer S. Wolff SN, et al. Bone Marrow Transplant. 2000 Apr;25(8):853-9. doi: 10.1038/sj.bmt.1702233. Bone Marrow Transplant. 2000. PMID: 10808206 Clinical Trial.
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group.
Fleming DR, Wolff SN, Fay JW, Brown RA, Lynch JP, Bolwell BJ, Stevens DA, Goodman SA, Greer JP, Stein RS, Pineiro LA, Collins RH, Goldsmith LJ, Herzig GP, Herzig RH. Fleming DR, et al. Among authors: lynch jp. Leuk Lymphoma. 1999 Sep;35(1-2):91-8. doi: 10.3109/10428199909145708. Leuk Lymphoma. 1999. PMID: 10512166 Clinical Trial.
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
Linker C, Anderlini P, Herzig R, Christiansen N, Somlo G, Bensinger W, Fay J, Lynch JP, Goodnough LT, Ashby M, Benyunes MC, Jones DV, Yang TA, Miller LL, Weaver C. Linker C, et al. Among authors: lynch jp. Biol Blood Marrow Transplant. 2003 Jun;9(6):405-13. doi: 10.1016/s1083-8791(03)00101-0. Biol Blood Marrow Transplant. 2003. PMID: 12813449 Free article. Clinical Trial.
615 results